D. E. Shaw & Co., Inc. Catalyst Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $22,452 - $111,015	-62,368 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $39,687 - $77,818	-77,818 Reduced 55.51%	62,368 $41,000
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $127,569 - $583,173	140,186 New	140,186 $128,000
Q1 2020 May 15, 2020	SELL	$3.5 - $8.51 $216,895 - $527,364	-61,970 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $280,104 - $490,182	61,970 New	61,970 $422,000
Q3 2019 Nov 14, 2019	SELL	$4.91 - $9.31 $111,457 - $211,337	-22,700 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $37,524 - $56,180	-5,300 Reduced 18.93%	22,700 $167,000
Q1 2019 May 15, 2019	BUY	$7.67 - $9.96 $22,243 - $28,884	2,900 Added 11.55%	28,000 $227,000
Q4 2018 Feb 14, 2019	BUY	$6.59 - $11.28 $62,605 - $107,160	9,500 Added 60.9%	25,100 $198,000
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $145,860 - $194,064	15,600 New	15,600 $168,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.